Mar 14 • 15:00 UTC 🇱🇻 Latvia LSM

Latvia has accumulated about one million tons of asbestos slate; disposal still costs a lot

Latvia faces a significant challenge with approximately one million tons of asbestos slate that poses severe health risks and costly disposal.

Latvia is currently confronting a serious issue with the accumulation of nearly one million tons of asbestos slate, a material recognized for its hazardous and carcinogenic properties. Asbestos particles can lead to skin irritation and allergic reactions, and when inhaled, they may cause severe illnesses, including lung cancer and tumors in various organs over many years after exposure. This has raised alarms among health and environmental authorities in Latvia regarding the long-term impacts on public health of such widespread asbestos materials in the country.

The production, import, and sale of asbestos-containing products, including slate, have been prohibited in Europe for some time, but previously installed materials can remain in use. Environmental experts warn that the state of any asbestos material deteriorates over time due to external conditions, leading to the gradual release of harmful substances into the environment. The State Environmental Service (VVD) strongly advises that asbestos waste must not be mixed with household or other types of waste, nor should it be sold or given away, underlining the critical importance of proper handling to mitigate health risks.

Despite the health risks associated with asbestos, the cost of professional disposal services remains a significant barrier for individuals and businesses in Latvia. This financial burden complicates the removal of hazardous materials and poses ongoing risks. The authorities are urged to find solutions for affordable waste management strategies for asbestos materials to safeguard public health and to follow through with regulations on asbestos handling and disposal. Overall, urgent measures need to be taken to address this environmental and health crisis in Latvia.

📡 Similar Coverage